- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
FDA Targets Risks From Reused Medical Devices
The U.S. Food and Drug Administration (FDA) is working with healthcare providers, manufacturers, organizations that set standards, and other government agencies to reduce the risk of infection from the inadequate “reprocessing” of medical devices such as clamps, forceps and endoscopes, that are reused in common surgical and diagnostic procedures.
The FDA has received reports of patients being exposed to microscopic amounts of blood, body fluids and tissue from other patients that may have occurred because the reusable devices were inadequately reprocessed and these contaminants were not removed.
Transmission of infection was extremely rare, but the potential for becoming infected by an inadequately processed device was there.
Read more at: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm284636.htm
Source: U.S. Food and Drug Administration
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
